We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Reduction of false positives using zone-specific prostate-specific antigen density for prostate MRI-based biopsy decision strategies

    Objectives

    To develop and test zone-specific prostate-specific antigen density (sPSAD) combined with PI-RADS to guide prostate biopsy decision...

    Charlie A. Hamm, Georg L. Baumgärtner, ... Tobias Penzkofer in European Radiology
    Article Open access 28 March 2024
  2. Fipronil disturbs the antigen-specific immune responses and GABAergic gene expression in the ovalbumin-immunized BALB/c mice

    Background

    Fipronil (FPN) is a broad-spectrum pesticide and commonly known as low toxicity to vertebrates. However, increasing evidence suggests that...

    Jui-Fang Kuo, Yin-Hua Cheng, ... Chia-Chi Wang in BMC Veterinary Research
    Article Open access 22 January 2024
  3. Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis

    Purpose

    To identify reasons for negative histopathology of specimens from prostate-specific membrane antigen (PSMA) radioguided surgery (PSMA-RGS) in...

    Daniel Koehler, Samuel Trappe, ... Tobias Maurer in European Journal of Nuclear Medicine and Molecular Imaging
    Article Open access 26 September 2023
  4. Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer

    Purpose

    To investigate the value of serum free prostate-specific antigen density (fPSAD) in the diagnosis of prostate cancer (PCa).

    Methods ...
    Bing-Zi Zou, Hong Wen, ... Meng-Ting Zhou in Irish Journal of Medical Science (1971 -)
    Article Open access 06 July 2023
  5. Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors

    T-cell dysregulation in chronic lymphocytic leukemia (CLL) associates with low response rates to autologous T cell-based therapies. How CLL affects...

    Anne W. J. Martens, Inga Kavazović, ... Arnon P. Kater in Leukemia
    Article 19 January 2023
  6. Increase of prostate-specific antigen doubling time predicts survival in metastatic castration-resistant prostate cancer patients undergoing radium therapy

    Objective

    Radium-223 (Ra-223) is an important treatment modality for bone-dominant metastatic castration-resistant prostate cancer (mCRPC). However,...

    Hsi-Huei Lu, Nan-Tsing Chiu, Mu-Hung Tsai in Annals of Nuclear Medicine
    Article 22 April 2024
  7. The effect of limited english proficiency on prostate-specific antigen screening in American men

    Purpose

    To evaluate how limited English proficiency (LEP) impacts the prevalence of prostate-specific antigen (PSA) screening in a contemporary,...

    Benjamin V. Stone, Muhieddine Labban, ... Quoc-Dien Trinh in World Journal of Urology
    Article 20 January 2024
  8. Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery

    Background

    Administration of adjuvant or salvage radiotherapy (RT) after prostate cancer (PCa) surgery is supported by clinical evidence and is a...

    Takuya Aizawa, Toshiya Maebayashi, ... Kenya Yamaguchi in BMC Urology
    Article Open access 04 October 2023
  9. Prostate Specific Membrane Antigen Expression in a Syngeneic Breast Cancer Mouse Model

    Purpose

    Prostate specific membrane antigen (PSMA) has been studied in human breast cancer (BCa) biopsies, however, lack of data on PSMA expression in...

    Aditi A. Shirke, **g Wang, ... James P. Basilion in Molecular Imaging and Biology
    Article Open access 17 May 2024
  10. Antigen specific T cells in people with obesity at five months following ChAdOx1 COVID-19 vaccination

    Background/Objectives

    People with obesity (PWO) face an increased risk of severe outcomes from COVID-19, including hospitalisation, ICU admission and...

    Neil E. Wrigley Kelly, Conor De Barra, ... Donal O’Shea in International Journal of Obesity
    Article 08 November 2022
  11. Head-to-head comparison of prostate-specific membrane antigen PET and multiparametric MRI in the diagnosis of pretreatment patients with prostate cancer: a meta-analysis

    Objectives

    To compare prostate-specific membrane antigen (PSMA) PET with multiparametric MRI (mpMRI) in the diagnosis of pretreatment prostate cancer...

    Jianglei Ma, Qinqin Yang, ... Shancheng Ren in European Radiology
    Article 20 November 2023
  12. Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) of prostate cancer: current and emerging applications

    Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) is transforming the management of patients with prostate cancer. In...

    Shamus Moran, Heather H. Cheng, ... Joseph E. Ippolito in Abdominal Radiology
    Article 22 February 2024
  13. Persistent virus-specific and clonally expanded antibody-secreting cells respond to induced self-antigen in the CNS

    B cells contribute to the pathogenesis of both cellular- and humoral-mediated central nervous system (CNS) inflammatory diseases through a variety of...

    Andreas Agrafiotis, Raphael Dizerens, ... Alexander Yermanos in Acta Neuropathologica
    Article Open access 25 January 2023
  14. Association of TyG index with prostate-specific antigen (PSA) in American men: results from NHANES, 2003–2010

    Background

    In recent years, triglyceride-glucose index (TyG) was a new indicator of insulin resistance, and it has been widely reported that it may be...

    Mengyu Zhang, Jiankang Zhang, Zengshu **ng in Irish Journal of Medical Science (1971 -)
    Article Open access 20 June 2023
  15. Interaction between drinking and dietary inflammatory index affects prostate specific antigen: a cross-sectional study

    Background

    Numerous studies have shown that the dietary inflammatory index (DII) is associated with adverse health effects. However, the relationship...

    **angtao Weng, Wenyue Tan, ... Shusheng Wang in BMC Geriatrics
    Article Open access 05 September 2023
  16. Targeting FLT3-specific chimeric antigen receptor T cells for acute lymphoblastic leukemia with KMT2A rearrangement

    CD19-specific chimeric antigen receptor T (CAR T) immunotherapy is used to treat B-cell malignancies. However, antigen-escape mediated relapse...

    Masaya Suematsu, Shigeki Yagyu, ... Tomoko Iehara in Cancer Immunology, Immunotherapy
    Article 10 October 2022
  17. Association between vitamin B2 intake and prostate-specific antigen in American men: 2003–2010 National Health and Nutrition Examination Survey

    Background

    Accumulating evidence suggests a pivotal role of vitamin B2 in the pathogenesis and progression of prostate cancer (PCa). Vitamin B2 intake...

    Jia-jie Lv, Lin-jie Zhang, ... Cheng-hao Yang in BMC Public Health
    Article Open access 03 May 2024
  18. Delphi consensus project on prostate-specific membrane antigen (PSMA)–targeted surgery—outcomes from an international multidisciplinary panel

    Purpose

    Prostate-specific membrane antigen (PSMA) is increasingly considered as a molecular target to achieve precision surgery for prostate cancer. A...

    Anne-Claire Berrens, Matthijs Scheltema, ... Fijs W. B. van Leeuwen in European Journal of Nuclear Medicine and Molecular Imaging
    Article 28 November 2023
  19. XFab-α4-1BB/CD40L fusion protein activates dendritic cells, improves expansion of antigen-specific T cells, and exhibits antitumour efficacy in multiple solid tumour models

    Background

    Additional immunotherapies are still warranted for non-responders to checkpoint inhibitors with refractory or relapsing cancers, especially...

    Bochun Wang, Yujie Liu, ... **n Gao in Cancer Immunology, Immunotherapy
    Article 21 October 2023
Did you find what you were looking for? Share feedback.